RxDoctor Payments Data

Emmanuel Menga, MD

Orthopaedic Surgery of the Spine · Miami, FLNPI 1790919124

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (33.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Globus Medical at 47.5% of the total.

$214,679in general payments, 2019–2025

Across 308 payments — averaging $697.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$102K
  • Evolution Spine, LLC$81K
  • Medtronic$12K
  • Bioventus LLC$6K
  • Synthes GmbH$6K
  • Seaspine Orthopedics Corporation$3K
  • plus $5K from 9 others

What the payments were for

  • Royalty or licence$70,77033%
  • Consulting fees$54,62525%
  • Speaking & faculty fees$44,60021%
  • Travel & lodging$33,04915%
  • Food & beverage$11,6345%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$214,679 in reported general payments places this provider in the 80th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$82,716
Medicare patients
81
Services billed
226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin37$460
Pregabalin24$294

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →